TotalMarketCap

Argenx Se

ARGXNasdaq NetherlandsHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$55.786 B

$898.86 -3.49%

Close of 6 Nov 2026

As of 6 Nov 2026, Argenx Se (ARGX) has a market capitalization of $55.8B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

61,883,306

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #2Gilead SciencesGILD$207.8B
  2. #3ModernaMRNA$96.5B
  3. #4Argenx SeARGX$55.8B
  4. #5Revolution MedicinesRVMD$38.5B
  5. #6BiogenBIIB$36.1B

What if Argenx Se were worth as much as…

Open the what-if tool →

Gold $28.2T

$454,971.96

Per share 506× higher

Bitcoin $1.53T

$24,617.74

Per share 27.4× higher

Apple $5.02T

$80,817.74

Per share 89.9× higher

Or at a round number

$100.0B$200.0B$500.0B$1.00T

Where these numbers come from

Share counts and financials for Argenx Se are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.